What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: MGI
95%DGNews: Berlex Voluntarily Recalls Ultravist(R) (Iopromide Injection) Injection 370 mgI/mL
95%DGNews: ASCO MEETING: MGI 114 Shows Antitumour Activity In Prostate Cancer Patients
93%DGNews: AACR: Irofulven (Hydroxymethylacyfulvene) Effective In Ovarian Cancer, Interim Results Show
93%DGNews: ASCO: Irofulven May Take Over Where Gemcitabine Fails In Pancreatic Cancer
93%DGNews: Salagen Provides A Variety Of Benefits To Sjogren's Syndrome Patients
90%DGNews: Dacogen(TM) (Decitabine) for Injection Receives U.S. Orphan Drug Designation for Patients With Acute Myeloid Leukemia
89%DGNews: Saforis NDA Accepted by U.S. FDA for Priority Review
89%DGNews: FDA Approves Azulfidine EN-Tabs (Sulfasalazine) To Treat Rheumatoid Arthritis In Children
88%DGNews: Berlex Issues Nationwide Recall of a Single Lot of Ultravist Injection 370 mgI/mL, 125 mL in the U.S.
88%DGNews: U.S. FDA Approves Dacogen (Decitabine) for Injection
88%DGNews: Gliadel Wafer Demonstrates Long-Term Survival Benefit for Patients With High-Grade Malignant Gliomas
88%DGNews: ACR MEETING: Salagen Tablets Safe, Effective For Dry Mouth Symptoms In Patients With Sjogren's Syndrome
88%DGNews: ACR: Prolonged Use Of Salagen Safe And Effective For Sjogren's Syndrome
88%DGNews: Salagen Indication Extended To Dry Mouth In Sjogren's Syndrome
84%DGNews: FDA Approves Aloxi (Palonosetron) For Treatment of Chemotherapy-Related Nausea and Vomiting
84%DGNews: Irofulven Holds Promise In Pancreatic Cancer In Patients Refractory to Gemzar (Gemcitabine)
83%DGNews: AACR-NCI-EORTC: Irofulven/Cisplatin Combination Well Tolerated, Promising in Advanced Solid Tumours
82%DGNews: Helsinn's New Antiemetic Drug Aloxi Receives Marketing Authorization in Europe
82%DGNews: Severity of Xerostomia Reduced When Taking Salagen Tablets
80%DGNews: Carmustine Wafer Implant Clinical Data Presented at Society for Neuro-Oncology Meeting
78%DGNews: Palonosetron's Benefit/Risk Profile Confirmed as Favorable in Postmarket Studies: Presented at MASCC-ISOO
77%DGNews: Patients With Chronic Myeloid Leukaemia Achieve Strong Response With Early Dasatinib Treatment: Presented at ASH
76%DGNews: Fospropofol Disodium Effective and Safe for Sedation During Colonoscopy: Presented at ACG
76%DGNews: SABCS: Investigational Oral Solution Reduces Breast Cancer Chemotherapy-Related Mucositis
75%DGNews: Fospropofol Disodium Effective and Safe for Sedation During Colonoscopy: Presented at ACG
75%DGNews: Investigative Fospropofol Appears Safe, Effective, and Potentially Opioid-Sparing in Colonoscopy Sedation: Presented at DDW
73%DGNews: Palonosetron Reduces Postoperative Nausea and Vomiting: Presented at ASA
72%DGNews: Decitabine Produces Cytogenic Responses in Patients With Myelodysplastic Syndromes: Presented at EHA
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.